INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Invivo Therapeutics Holdings Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2022.
  • Invivo Therapeutics Holdings Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $47.5M, a 6.07% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $47.5M +$2.72M +6.07% Dec 31, 2022 10-K 2023-03-01
Q4 2021 $44.8M +$2.58M +6.09% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $42.3M +$581K +1.39% Dec 31, 2020 10-K 2022-03-07
Q4 2019 $41.7M +$2.99M +7.73% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $38.7M +$2.69M +7.49% Dec 31, 2018 10-K 2020-02-20
Q4 2017 $36M -$7.91M -18% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $43.9M +$9.41M +27.3% Dec 31, 2016 10-K 2018-03-12
Q4 2015 $34.5M +$8.73M +33.9% Dec 31, 2015 10-K 2017-03-10
Q4 2014 $25.8M +$6.29M +32.3% Dec 31, 2014 10-K 2016-03-04
Q4 2013 $19.5M +$7.74M +65.9% Dec 31, 2013 10-K 2015-03-11
Q4 2012 $11.7M +$4.78M +68.6% Dec 31, 2012 10-K 2014-03-17
Q4 2011 $6.96M Dec 31, 2011 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.